JNCI-Journal of the National Cancer Institute

Article	Citations
Correction to: ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications	337
Vertical integration in oncology: what does it mean for patients with cancer?	208
Re: Deng and Heybati	147
Addressing Diversity, Equity, and Inclusion at the JNCI Journals	134
Factors associated with timely COVID-19 vaccination in a population-based cohort of patients with cancer	132
The Unrelenting Impact of Poverty on Cancer: Structural Inequities Call for Research and Solutions on Structural Determinants	132
The National Cancer Institute Funding of Global Research: Lessons Learned and Opportunities Going Forward	127
RE: Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers	123
Response to Liu and Zhang	117
Pre- and post-diagnostic use of antihypertensive medications and stage I-III colorectal cancer survival: prospective cohort study	116
The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment	106
Mediators of Racial Disparities in Heart Dose Among Whole Breast Radiotherapy Patients	87
Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination	71
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial	69
Reduced adipose tissue with limited loss of lean mass after weight loss: results from the Prostate Active Lifestyle Study	65
Systematic investigation of genetically determined plasma and urinary metabolites to discover potential interventional targets for colorectal cancer	65
Increasing diversity in clinical trials: demographic trends at the National Cancer Institute, 2005-2020	63
Evaluating a blood test for colon cancer screening: how simulation modeling can inform clinical policy making and research	62
Survivorship after adolescent and young adult cancer: models of care, disparities, and opportunities	61
Ethylene oxide emissions and incident breast cancer and non-Hodgkin lymphoma in a US cohort	61
Dyslipidemia and cardiovascular disease among childhood cancer survivors: a St. Jude Lifetime Cohort report	57
Li-Fraumeni Syndrome in the Cancer Genomics Era	55
Understanding risk factors for endometrial cancer in young women	52
Method of primary breast cancer detection and the disease-free interval, adjusting for lead time	51
Medication–Associated Phthalate Exposure and Childhood Cancer Incidence	51

Long-term aspirin use and cancer risk: a 20-year cohort study	51
RE: Use of artificial intelligence for cancer clinical trial enrollment	50
Impact of knowledge of human papillomavirus positivity on cervical cytology performance in Latin America	47
Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study	47
Treatment deescalation for older women with favorable breast cancers: patient values and shared decision making	46
Determinants of late metastases in renal cell carcinoma	45
Behavioral Research in Cancer Prevention and Control: Emerging Challenges and Opportunities	45
Association Between Medicaid Expansion Under the Affordable Care Act and Survival Among Newly Diagnosed Cancer Patients	45
Cancer control co-benefits of the climate-related provisions in the American Inflation Reduction Act	44
Evaluating colonoscopy quality by performing provider type	44
Patients’ attitudes and preferences toward delayed disease progression in the absence of improved survival	44
RE: Prevalence of cancer survivors in the United States	43
Premature aging as an accumulation of deficits in young adult survivors of pediatric cancer	42
Correction to: Quality of Life in Older Adults After Major Cancer Surgery: The GOSAFE International Study	42
Optimizing public-private partnerships to support clinical cancer research	42
Lower Exome Sequencing Coverage of Ancestrally African Patients in The Cancer Genome Atlas	41
Toxicity risk score and clinical decline after adjuvant chemotherapy in older breast cancer survivors	41
RE: Autoimmune disease and the risk of anal cancer in the US elderly population	41
Health-related quality of life by race, ethnicity, and country of origin among cancer survivors	41
Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) Study	40
Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line col	40
Response to Omoleye, Esserman, Olufunmilayo	39
Exposure to polycyclic aromatic hydrocarbons, volatile organic compounds, and tobacco-specific nitrosamines and incidence of esophageal cancer	39
An Artificial Intelligence System for the Detection of Bladder Cancer via Cystoscopy: A Multicenter Diagnostic Study	39
Response of bilateral Wilms tumor to chemotherapy suggests histologic subtype and guides treatment	38
Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis	37
Putting patients first to redefine prostate cancer classifications	37
Dietary interventions in cancer: a systematic review of all randomized controlled trials	36
Leisure-time physical activity after diagnosis and survival by cancer type: a pooled analysis	36
Urgent need to mitigate disparities in federal funding for cancer research	36
Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome	35
Contribution of health insurance to racial and ethnic disparities in advanced-stage diagnosis of 10 cancers	35
Epidemiology of early vs late recurrence among women with early stage estrogen receptor–positive breast cancer in the Pathways Study	34
Impacts of an Opioid Safety Initiative on US Veterans Undergoing Cancer Treatment	34
Assessing racial, ethnic, and nativity disparities in US cancer mortality using a new integrated platform	33
Association between diet quality and ovarian cancer risk and survival	33
Facility exposure to wildfire disasters and hospital length of stay following lung cancer surgery	32
Physical activity and checkpoint inhibition: association with toxicity and survival	32
RE: Heterozygous BRCA1/BRCA2 and mismatch repair gene pathogenic variants in children and adolescents with cancer	32
The decision aid is the easy part: workflow challenges of shared decision making in cancer care	31
HPV vaccine impact: genotype-specific changes in cervical pre-cancer share similarities with changes in cervical screening cytology	31
Editor’s Note on: Hypoxia-inducible Factor 1α and Antiangiogenic Activity of Farnesyltransferase Inhibitor SCH66336 in Human Aerodigestive Tract Cancer	31
Social vulnerability and survival in 112 000 adolescents and young adults with cancer: a population-based study	31
Long-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy	30
RE: Lower Exome Sequencing Coverage of Ancestrally African Patients in the Cancer Genome Atlas	30
Age-standardised (world) incidence rates of the 33 leading cancers in the U.S., the European Union (EU-27), Sub-Saharan Africa, and China in 2022, all ages, both sexes combined	30
Evaluating Prostate-Specific Antigen Screening for Young African American Men With Cancer	30
Risk prediction of hepatitis B or C or HIV among newly diagnosed cancer patients	29
Selection of Adjuvant Endocrine Therapy for Women With Breast Cancer in Menopausal Transition: Is It Simpler Than We Thought?	29
Smoking as a prognostic factor for survival in patients with disseminated germ cell cancer	29

Can early prostate cancer screening help address mortality disparities among Black men?	28
Early-Onset Colorectal Cancer: The Mystery Remains	28
Risk of early death in adolescents and young adults with cancer: a population-based study	28
Association of N-terminal pro–brain natriuretic peptide with survival among US cancer survivors	28
Engineered allogeneic stem cells orchestrate T lymphocyte–driven immunotherapy in immunosuppressive leptomeningeal brain metastasis	27
Prognostic factors in localized pancreatic ductal adenocarcinoma after neoadjuvant therapy and resection: a systematic review and meta-analysis	27
Pancreatic Ductal Carcinoma Risk Associated With Hereditary Cancer-Risk Genes	27
Cancer Risk Prediction Paradigm Shift: Using Artificial Intelligence to Improve Performance and Health Equity	27
Proportion of patients in phase 2 oncology trials receiving treatments that are ultimately approved	26
Ambient ultraviolet A, ultraviolet B, and risk of melanoma in a nationwide United States cohort, 1984-2014	26
Maternal serum concentrations of per- and polyfluoroalkyl substances and childhood acute lymphoblastic leukemia	26
Revisiting the standard blueprint for biomarker development to address emerging cancer early detection technologies	26
Digital Health Applications in Oncology: An Opportunity to Seize	26
Protecting vulnerable patient populations from climate hazards: the role of the nation’s cancer centers	25
Response to Javier-DesLoges, Salmasi, Jamieson, and Anger	25
Response to Song	25
RE: Informing women about overdetection in breast cancer screening: Two-year outcomes from a randomized trial	24
Preexisting evidence and outcome of phase III trials in gastrointestinal oncology: a systematic review	24
Estimating human papillomavirus vaccine efficacy from a single-arm trial: proof-of-principle in the Costa Rica Vaccine Trial	24
Room to Grow: The Need for Cancer Site–Specific Research Into Biomarkers of Aging and Immunity in People With HIV	24
Alzheimer disease–related biomarkers and cancer-related cognitive decline: the Thinking and Living with Cancer study	24
Response to Semprini and Osazuwa-Peters	23
Childhood Cancer-Connect: Identifying solutions to elevating the cancer experience for adolescents and young adults with cancer	23
Minding the Gap: Cancer-Related Survival Disparities in Adolescent and Young Adult Survivors	23
Genome-wide DNA methylation and transcriptomic patterns of precancerous gastric cardia lesions	23
Simplifying Survivorship Care Planning: A Randomized Controlled Trial Comparing 3 Care Plan Delivery Approaches	23
Impact of major depressive disorder on breast cancer outcomes: a national retrospective cohort study	22
Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic patients	22
Correction to: Frameshift mutations in peripheral blood as a biomarker for surveillance of Lynch syndrome	22
Listening to the Patient Voice Adds Value to Cancer Clinical Trials	22
Association of longer telomere length in cancer cells and cancer-associated fibroblasts with worse prognosis	22
The unique risk factor profile of triple-negative breast cancer: a comprehensive meta-analysis	22
Reevaluating Disease-Free Survival as an Endpoint vs Overall Survival in Stage III Adjuvant Colon Cancer Trials	21
Test performance metrics for breast, cervical, colon, and lung cancer screening: a systematic review	21
Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling	21
Outcomes after solid organ transplantation in survivors of childhood, adolescent, and young adult cancer: a population-based study	21
Red-flag signs and symptoms for earlier diagnosis of early-onset colorectal cancer	21
Social Determinants of Health and Cancer Care: Where Do We Go From Here?	21
Ten-year update: NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancer	21
Rising incidence of early-onset colorectal cancer: impact of anatomy and histology	20
Risk of atherosclerotic cardiovascular disease after cancer diagnosis: findings from three prospective cohort studies	20
Differences in tumor-associated T-cell receptor repertoires between early-onset and average-onset colorectal cancer	20
The use of master protocols for efficient trial design to evaluate radiotherapy interventions: a systematic review	20
Real-world impact of the platinum chemotherapy shortage on US patients with advanced cancer	19
Design of randomized controlled trials to estimate cancer-mortality reductions from multicancer detection screening	19
Breast and Prostate Cancer Risks for MaleBRCA1andBRCA2Pathogenic Variant Carriers Using Polygenic Risk Scores	19
Time to change the paradigm for primary endpoints in cancer screening trials?	19
Immune and gene-expression profiling in estrogen receptor low and negative early breast cancer	19
Comparing characteristics of individuals screened for lung cancer with 2021 vs 2013 US Preventive Services Task Force recommendations	19
Shifting the Paradigm: Reimagining Approaches to Diversifying the Leadership of the Nation’s Cancer Centers	19
Expression of Concern: Delta-Like Ligand 4–Notch Blockade and Tumor Radiation Response	19
The evolving landscape of oropharyngeal cancer: a window of opportunity for primary prevention	19
Correction to: Delta-Like Ligand 4–Notch Blockade and Tumor Radiation Response	19
Prophylactic human papillomavirus vaccination for prevention of oropharyngeal cancer in older men: is the juice worth the squeeze?	19
Characteristics of patient navigation programs in the Cancer Moonshot ACCSIS colorectal cancer screening initiative	18
Human papillomavirus–related squamous cell carcinomas after blood or marrow transplantation—a Blood or Marrow Transplant Survivor Study report	18
Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease	18
Symptoms and early-onset colorectal cancer: red flags are common flags!	18
Opioid tapering in older cancer survivors does not increase psychiatric or drug hospitalization rates	18
Association of differential censoring with survival and suboptimal control arms among oncology clinical trials	18
Climate change and cancer: the Environmental Justice perspective	17
Leveraging national and global political determinants of health to promote equity in cancer care	17
Reducing—a little—the high price of randomized trials of the efficacy of multicancer early detection	17
Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis	17
Circulating proteome for pulmonary nodule malignancy	17
Re: Incidence of in situ vs invasive melanoma: testing the “obligate precursor” hypothesis	17
Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer	17
Streamlining the conduct of cancer clinical trials: new standard data collection practices for National Cancer Institute late-phase clinical studies	17
Beyond survival: a closer look at lead-time bias and disease-free intervals in mammography screening	17
Editor’s Note: Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1	17
Subsequent Primary Cancer Risk Among 5-Year Survivors of Adolescent and Young Adult Cancers	17
A validated estimate of visceral adipose tissue volume in relation to cancer risk	17
Response to Etminan	16
Call for Emergency Action to Limit Global Temperature Increases, Restore Biodiversity, and Protect Health	16
Disparities in cancer incidence by rurality in California	16
Tracking community outreach and engagement activities among National Cancer Institute-designated cancer centers	16
Increasing radiation therapy and lower survival for human papillomavirus–related oropharynx cancer associated with a shift to community cancer center care	16
Melanoma thickness and long-term mortality	16
Genetic risk and likelihood of prostate cancer detection on first biopsy by ancestry	16
Platinum ineligibility and survival outcomes in patients with advanced urothelial carcinoma receiving first-line treatment	16

Developing the next-generation cancer research workforce in the National Institutes of Health Intramural Research Program	16
RE: Progression of Frailty in Survivors of Childhood Cancer: A St. Jude Lifetime Cohort Report	16
Cardiovascular and Metabolic Diagnoses Associated With Novel Hormonal Agents for Prostate Cancer in Nontrial Populations	16
Treating the Whole Patient With Cancer: The Critical Importance of Understanding and Addressing the Trajectory of Medical Financial Hardship	15
Cancer Incidence in World Trade Center Rescue and Recovery Workers: 14 Years of Follow-Up	15
Tucatinib promotes immune activation and synergizes with programmed cell death–1 and programmed cell death–ligand 1 inhibition in HER2-positive breast cancer	15
Liver elastography-based risk score for predicting hepatocellular carcinoma risk	15
Stat Bite: Variations in nasopharyngeal cancer incidence rates according to registries included in Cancer Incidence in Five Continents, Volume XII	15
Correction to: Mortality among patients with diffuse large B-cell lymphoma and mental disorders: a population-based study	15
The Cancer Moonshot Immuno-Oncology Translational Network at 5: accelerating cancer immunotherapies	15
Mortality among patients with diffuse large B-cell lymphoma and mental disorders: a population-based study	15
Response to Sorscher	14
Assessment of intermediate-term mortality following pancreatectomy for cancer	14
Trends in breast cancer–specific death by clinical stage at diagnoses between 2000 and 2017	14
Addressing health-related quality of life inequities in cancer: where do we go from here?	14
Impact of racial disparities in follow-up and quality of colonoscopy on colorectal cancer outcomes	14
Corrigendum to: Realizing the Promise of Personalized Colorectal Cancer Screening in Practice	14
Long-term behavioral symptom clusters among survivors of early-stage breast cancer: Development and validation of a predictive model	14
The risk and benefit profiles of US-eligible lung cancer screening attendees vs nonattendees	14
Surgical Care for Older Adults: The Importance of Patient-Centered Outcomes in Daily Practice	14
Changes in cancer mortality after Medicaid expansion and the role of stage at diagnosis	14
Identification of the JNK-Active Triple-Negative Breast Cancer Cluster Associated With an Immunosuppressive Tumor Microenvironment	14
Untangling the Relationship Between Clonal Hematopoiesis and Ovarian Cancer Therapies	14
Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules	14
RE: The impact of multidisciplinary cancer conferences on overall survival: a meta-analysis	14
Lung Cancer Absolute Risk Models for Mortality in an Asian Population using the China Kadoorie Biobank	14
Risk factors for breast cancer subtypes by race and ethnicity: a scoping review	13
Comparative cost-effectiveness of contemporary treatment strategies for stage IIA seminoma	13
Response to Maltoni, Puccetti, Poli, et al.	13
Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC: a reconstructed individual patient data meta-analysis	13
Human papillomavirus–associated anal squamous cell carcinoma: sociodemographic, geographic, and county-level economic trends in incidence rates—United States, 2001-2019	13
Influence of endoxifen on mammographic density: results from the KARISMA-Tam trial	13
Low physical function following cancer diagnosis is associated with higher mortality risk in postmenopausal women	13
COVID-19 vaccination, infection, and symptoms among cancer survivors in the United States	13
Stat Bite: Convergence of long-term trends in cervix uteri cancer incidence among Black and White women from 1975 to 2021	13
Helicobacter pylori Modulated Host Immunity in Gastric Cancer Patients With S-1 Adjuvant Chemotherapy	13
Assessment of Caregivers’ Burden When Caring for Patients With Pancreatic and Periampullary Cancer	13
The association of where patients with prostate cancer live and receive care on racial treatment inequities	13
Effect of chronic disease on racial difference in COVID-19–associated hospitalization among cancer patients	13
Response to Khouri and Suissa	13
Risk factors for second primary breast cancer by laterality, age, and race and ethnicity	13
The evolution of NCI’s Health Information National Trends Survey: methods, data, and future directions	13
Inflammatory and insulinemic dietary patterns and risk of endometrial cancer among US women	13
Correction to: Effect of the p53 P72R Polymorphism on Mutant TP53 Allele Selection in Human Cancer	13
Prevalence of anal cytology screening among persons with HIV and lack of access to high-resolution anoscopy at HIV care facilities	13
The intratumor microbiome is associated with microsatellite instability	12
Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients	12
Correction to: Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules	12
You Get What You Pay For: Breast MRI Screening of Women With Dense Breasts Is Cost-effective	12
Cancer risk in patients with diverticular disease: A nationwide cohort study	12
Genome-Wide Interaction Analysis of Genetic Variants With Menopausal Hormone Therapy for Colorectal Cancer Risk	12
Comparing waist circumference with body mass index on obesity-related cancer risk: a pooled Swedish study	12
Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials: a meta-epidemiological study	12
Centering patients with advanced cancer includes supporting their caregivers	12
RE: Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients	12
Using neurocognitive phenotypes to inform interventions for adult survivors of childhood cancer	12
Time-restricted eating and cancer: lessons learned and considerations for a path forward	12
Metformin boosts antitumor immunity and improves prognosis in upfront resected pancreatic cancer: an observational study	12
Structural inequities in the availability of prostate cancer clinical trial opportunities	12
RE: Glucagon-like peptide 1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data	12
Response to Wernly, Datz, and Wernly	12
Histopathological response to chemotherapy and survival of mucinous type gastric cancer	12
Impact of pain and adverse health outcomes on long-term US testicular cancer survivors	12
COVID-19 severity by vaccination status in the NCI COVID-19 and Cancer Patients Study (NCCAPS)	11
Frailty and outcomes in adults undergoing systemic anticancer treatment: a systematic review and meta-analysis	11
An international multi-institutional validation of T1 sub-staging of intraductal papillary mucinous neoplasm-derived pancreatic cancer	11
Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study	11
Correction to: FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas	11
Trends in new and persistent opioid use in older adults with and without cancer	11
Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study	11
PUBLISHER’S NOTE	11
Pan-cancer genomic analysis reveals FOXA1 amplification is associated with adverse outcomes in non–small cell lung, prostate, and breast cancers	10
Cascade testing for hereditary cancer: comprehensive multigene panels identify unexpected actionable findings in relatives	10
Speeding implementation in cancer: The National Cancer Institute’s Implementation Science Centers in Cancer Control	10
Ten years of robot-assisted versus laparoscopic total mesorectal excision for rectal cancer (short-term RESOLUTION)	10
Interactions of Age and Blood Immune Factors and Noninvasive Prediction of Glioma Survival	10
The Oncology Care Model and Adherence to Oral Cancer Drugs: A Difference-in-Differences Analysis	10
Strength of evidence underlying the CMS-FDA parallel review of comprehensive genomic profiling tests in the cancer setting	10
A working group report from the 2024 National Cancer Institute / Gynecologic Cancer Steering Committee endometrial cancer clinical trials planning meeting: refining the approach to endometrial cancer	10
Neoadjuvant BRAF-targeted therapy for ameloblastoma of the mandible: an organ preservation approach	10
Association between a network-based physician linchpin score and cancer patient mortality: a SEER-Medicare analysis	10
RE: Decreasing Incidence of Estrogen Receptor–Negative Breast Cancer in the United States: Trends by Race and Region	10
Mortality in children with congenital heart disease and cancer: new insights, ongoing challenges	10
The most frequent forms of premature death from cancer in 185 countries in 2022 (both sexes combined)	10
RE: Long-term survival across Breslow thickness categories: findings from a population-based study of 210 042 Australian melanoma patients	10
Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE)	10
Prostate cancer disparities among American Indians and Alaskan Natives in the United States	10
Antibiotic Use Impacts Colorectal Cancer: A Double-Edged Sword by Tumor Location?	10
Biological and Molecular Factors Predicting Response to Adoptive Cell Therapies in Cancer	10
Improving our understanding of the complex relationship between cancer-related cognitive decline and Alzheimer’s disease	10
RE: Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer	9
Cancer Relevance of Human Genes	9
Vaginal Estrogen Therapy for the Genitourinary Symptoms of Menopause: Caution or Reassurance?	9
Benefit of Biennial Fecal Occult Blood Screening on Colorectal Cancer in England: A Population-Based Case-Control Study	9
Limiting surveillance in individuals with the Palestinian TP53 p. R181C founder variant—is it too soon to draw conclusions?	9